Danske Bank’s Redhill Biopharma RDHL Stock Holding History

Danske Bank’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$17	–	1602
2024 Q3	$17	Buy	+2	New	+$20	﹤0.01%	1506

Other funds holding RDHL

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

VWM

Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

Danske Bank's RDHL Position: Q4 2024 in Review

Danske Bank sold out of Redhill Biopharma (RDHL) in Q4 2024, closing a stake of 2 shares — an estimated $17 sold.

Danske Bank first reported a position in RDHL in Q3 2024 and held it in 1 quarter. The position peaked at $17 in Q3 2024. 11 funds tracked by Wall St. Rank hold RDHL as of Q4 2024.

Danske Bank reported no remaining Redhill Biopharma position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 2 Redhill Biopharma shares in Q4 2024, an estimated $17.
Danske Bank first reported a position in Redhill Biopharma in Q3 2024 and held it in 1 quarter.
Danske Bank's Redhill Biopharma position peaked at $17 in Q3 2024.
11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.